...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Long covid trials

In my opinion, HL the ~$3 Billion dollar market cap pharma would be the main stumbling block in a BP acquisition. 

Besides, as far as I can tell, Resverlogix has in no time ever spoken about searching for a BP buyout. They hired Eversana for commercializing "Apabetalone" in-house as I understand it.

 

Koo

 

Share
New Message
Please login to post a reply